-
Explaining Psychiatric Comorbidities in Patients With Skin Conditions: The Importance of Clinical Characteristics and Patient-Reported Disease Impact
Sep 9, 2025, 16:22 PM -
A Comprehensive Assessment of Clinical Studies on Artificial Intelligence-Enabled Interventions: Uncovering Trends and Potential Implications
Sep 9, 2025, 16:22 PM -
The Economic Burden of Parkinson's Disease in the Netherlands: From Societal Impact to Investments in Health Solutions
Sep 9, 2025, 16:22 PM -
Cost of Treatment of Metastatic Non-Small Lung Cancer in Sweden, 2011-2023
Sep 9, 2025, 16:22 PM -
Estimating the Long-Term Impact of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Treatments on the Annual Decline of Percent-Predicted Forced Expiratory Volume in One Second (ppFEV1) Compared to Established Clinical Management...
Sep 9, 2025, 16:22 PM -
Innovation on Hold: A 2020-2025 Analysis of the Conditional Drug Reimbursement Framework
Sep 9, 2025, 16:22 PM -
Evaluating the Potential Health and Economic Impact of V116 vs. PCV20 on Invasive Pneumococcal Disease Among Adults in the United Kingdom
Sep 9, 2025, 16:22 PM -
Clinically Informed, Cost-Sensitive Machine Learning for Predicting Hospital-Acquired Pressure Injuries: A Practical Approach Using Routinely Collected Data
Sep 9, 2025, 16:22 PM -
Frequency and Impact of External Comparator Arms in Oncology HTA Assessments With Single-Arm Trials in the UK, France, and Germany From 2014 to 2024
Sep 9, 2025, 16:22 PM -
Balancing Fit and Accuracy: Evaluating Survival Model Projections With Immature Data in Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Evidence Synthesis: A Systematic Review and Meta-Analysis of Emerging Biologics for Improving Skeletal Health in Osteogenesis Imperfecta
Sep 9, 2025, 16:22 PM -
Broader Economic Effects of Investment in Cancer Control in Commonwealth Countries
Sep 9, 2025, 16:22 PM -
The AI-Only Workflow: Model and Report Adaptation Without Human Setup
Sep 9, 2025, 16:22 PM -
Relationship Between Cost-Effectiveness Threshold and Drug Reimbursement in Spain, Italy, and France
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Inhaled Levodopa for Managing OFF Episodes in Patients With Parkinson’s Disease
Sep 9, 2025, 16:22 PM -
Exploring the Healthcare Resource Utilization (HCRU) Associated With Chorea in Patients With Huntington's Disease (HD): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Second- or Later-Line Treatments for Advanced and Metastatic Gastric Cancer: A Network Meta-Analysis Comparing Treatments to Paclitaxel
Sep 9, 2025, 16:22 PM -
Clinical and Economic Perspectives on Influenza and COVID-19 Vaccine Combinations
Sep 9, 2025, 16:22 PM -
Analysis of the Impact of the TelE-Medicine Program for Medically Underserved Area on Hospitalization Rates Among Diabetic Patients in Medically Underserved Areas
Sep 9, 2025, 16:22 PM -
Physician Perspectives on Unmet Need and Treatment Options Among Patients With Relapsed Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Canada: Findings From Qualitative Interviews
Sep 9, 2025, 16:22 PM
